CURE Epilepsy – Catalyst Axard
Ends on 10 June 2025
The CURE Epilepsy Catalyst Award (2 years / $250,000) supports nimble development of data necessary to advance ideas toward larger commercialization funding opportunities and is not intended to replace those opportunities.